Hofbauer LC - Search Results

1

Estrogen Regulates Bone Turnover by Targeting RANKL Expression in Bone Lining Cells.

Streicher C, Heyny A, Andrukhova O, Haigl B, Slavic S, Schüler C, Kollmann K, Kantner I, Sexl V, Kleiter M, Hofbauer LC, Kostenuik PJ, Erben RG. Streicher C, et al. Among authors: hofbauer lc. Sci Rep. 2017 Jul 25;7(1):6460. doi: 10.1038/s41598-017-06614-0. Sci Rep. 2017. PMID: 28744019 Free PMC article.

2

Osteoprotegerin, RANK, and RANK ligand: the good, the bad, and the ugly in rheumatoid arthritis.

Hofbauer LC, Heufelder AE, Erben RG. Hofbauer LC, et al. J Rheumatol. 2001 Apr;28(4):685-7. J Rheumatol. 2001. PMID: 11327234 Review. No abstract available.

3

Skeletal effects of cyclosporin A are gender related in rats.

Erben RG, Brunner KS, Breig B, Eberle J, Goldberg M, Hofbauer LC. Erben RG, et al. Among authors: hofbauer lc. Endocrinology. 2003 Jan;144(1):40-9. doi: 10.1210/en.2002-220513. Endocrinology. 2003. PMID: 12488328

4

Fatal attraction: why breast cancer cells home to bone.

Hofbauer LC, Rachner T, Singh SK. Hofbauer LC, et al. Breast Cancer Res. 2008;10(1):101. doi: 10.1186/bcr1848. Epub 2008 Jan 25. Breast Cancer Res. 2008. PMID: 18226190 Free PMC article.

5

Inhibition of lamin A/C attenuates osteoblast differentiation and enhances RANKL-dependent osteoclastogenesis.

Rauner M, Sipos W, Goettsch C, Wutzl A, Foisner R, Pietschmann P, Hofbauer LC. Rauner M, et al. Among authors: hofbauer lc. J Bone Miner Res. 2009 Jan;24(1):78-86. doi: 10.1359/jbmr.080902. J Bone Miner Res. 2009. PMID: 18767923 Free article.

6

Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL.

Hofbauer LC, Zeitz U, Schoppet M, Skalicky M, Schüler C, Stolina M, Kostenuik PJ, Erben RG. Hofbauer LC, et al. Arthritis Rheum. 2009 May;60(5):1427-37. doi: 10.1002/art.24445. Arthritis Rheum. 2009. PMID: 19404943 Free article.

7

Orchiectomy upregulates free soluble RANKL in bone marrow of aged rats.

Proell V, Xu H, Schüler C, Weber K, Hofbauer LC, Erben RG. Proell V, et al. Among authors: hofbauer lc. Bone. 2009 Oct;45(4):677-81. doi: 10.1016/j.bone.2009.05.024. Epub 2009 Jun 6. Bone. 2009. PMID: 19501680

8

Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice.

Helas S, Goettsch C, Schoppet M, Zeitz U, Hempel U, Morawietz H, Kostenuik PJ, Erben RG, Hofbauer LC. Helas S, et al. Among authors: hofbauer lc. Am J Pathol. 2009 Aug;175(2):473-8. doi: 10.2353/ajpath.2009.080957. Epub 2009 Jul 9. Am J Pathol. 2009. PMID: 19590040 Free PMC article.

9

Denosumab for bone diseases: translating bone biology into targeted therapy.

Tsourdi E, Rachner TD, Rauner M, Hamann C, Hofbauer LC. Tsourdi E, et al. Among authors: hofbauer lc. Eur J Endocrinol. 2011 Dec;165(6):833-40. doi: 10.1530/EJE-11-0454. Epub 2011 Aug 18. Eur J Endocrinol. 2011. PMID: 21852390 Review.

10

Regulation of bone mass and osteoclast function depend on the F-actin modulator SWAP-70.

Garbe AI, Roscher A, Schüler C, Lutter AH, Glösmann M, Bernhardt R, Chopin M, Hempel U, Hofbauer LC, Rammelt S, Egerbacher M, Erben RG, Jessberger R. Garbe AI, et al. Among authors: hofbauer lc. J Bone Miner Res. 2012 Oct;27(10):2085-96. doi: 10.1002/jbmr.1670. J Bone Miner Res. 2012. PMID: 22648978 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

440 results

Search Page